Bioventus (BVS) Current Assets (2020 - 2026)
Bioventus' (BVS) quarterly Current Assets came in at $249.8 million in Q1 2026, little changed YoY from $249.4 million in Q1 2025, and down 8.44% on a QoQ basis from $272.8 million in Q4 2025.
Bioventus (BVS) Current Assets (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Current Assets data on file, last reported at $249.8 million in Q1 2026.
- Quarterly Current Assets changed 0.18% year-over-year to $249.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $249.8 million (changed 0.18% YoY) and the FY2025 annual result came in at $272.8 million, down 1.0% from the prior year.
- Current Assets fell to $249.8 million in Q1 2026, from $272.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $308.9 million in Q2 2024 to a low of $245.4 million in Q2 2022.
- A 5-year average of $272.4 million and a median of $272.6 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets gained 25.78% — and 2024, when it retreated 13.85%.
- Tracing BVS's Current Assets over 5 years: stood at $272.6 million in 2022, then slipped by 1.68% to $268.0 million in 2023, then increased by 2.84% to $275.6 million in 2024, then slipped by 1.0% to $272.8 million in 2025, then decreased by 8.44% to $249.8 million in 2026.
- The last three Current Assets figures came in at $249.8 million (Q1 2026), $272.8 million (Q4 2025), and $280.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn | 257.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 257.53 Mn |
| Mar 28, 2026 | 249.81 Mn |
| Dec 31, 2025 | 272.84 Mn |
| Sep 27, 2025 | 280.90 Mn |
| Jun 28, 2025 | 275.20 Mn |
| Mar 29, 2025 | 249.37 Mn |
| Dec 31, 2024 | 275.61 Mn |
| Sep 28, 2024 | 298.69 Mn |
| Jun 29, 2024 | 308.88 Mn |
| Mar 30, 2024 | 265.90 Mn |
| Dec 31, 2023 | 268.00 Mn |
| Sep 30, 2023 | 249.45 Mn |
| Jul 1, 2023 | 260.64 Mn |
| Apr 1, 2023 | 308.66 Mn |
| Dec 31, 2022 | 272.58 Mn |
| Oct 1, 2022 | 271.08 Mn |
| Jul 2, 2022 | 277.16 Mn |
| Apr 2, 2022 | 245.40 Mn |
| Dec 31, 2021 | 263.10 Mn |
| Oct 2, 2021 | 246.08 Mn |